Marina I. Miller

Invalidity Of A Patent Claiming Antibodies Characterized By Their Function In View Of Amgen

A Broad Outline Of A Genus's Perimeter Is Insufficient For Written Description Of The Members Of The Genus

Anticipation Under The Public Use Bar

USPTO Announces All Patent Term Extension Requests To Be Filed Electronically

Claims Directed To Detecting Natural Phenomena Using Conventional Techniques Are Patent Ineligible

A Class Of 957 Predicted Salts Is Insufficient To Meet The ‘At Once Envisage' Standard

USPTO Extends Cancer Immunotherapy Pilot Program

Failure To Identify The Invention And To Explain How You Do It May Lead To Invalidity Under Section 101

Product-by-Process Claim: The Focus Is On The Product And Not The Process Of Making It

Patent Invalidation Under Section102(b)'s On-Sale Bar Based On A Letter Including Commercial Terms Sent Before The Critical Date